{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:49:57Z","timestamp":1785786597329,"version":"3.56.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/rlu.0b013e3181feeb72","type":"journal-article","created":{"date-parts":[[2010,12,11]],"date-time":"2010-12-11T02:28:19Z","timestamp":1292034499000},"page":"17-20","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic Value of Bone Scintigraphy in Cancer Patients With Osteonecrosis of the Jaw"],"prefix":"10.1097","volume":"36","author":[{"given":"Tim","family":"Van den Wyngaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon T.","family":"Huizing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fossion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Vermorken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/annonc\/mdl294","article-title":"Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?","volume":"17","author":"Van den Wyngaert","year":"2006","journal-title":"Ann Oncol"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.","volume":"23","author":"Hoff","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R3-4-20210204","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update.","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0b013e32819f820b","article-title":"Osteonecrosis of the jaw related to the use of bisphosphonates.","volume":"19","author":"Van den Wyngaert","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","article-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.","volume":"20","author":"Ripamonti","year":"2009","journal-title":"Ann Oncol"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Ann Oncol"},{"key":"R7-4-20210204","first-page":"271","article-title":"Bisphosphonate associated osteonecrosis of the jaw (ONJ) in cancer patients: conservative management techniques and consolidated guidelines.","volume":"2","author":"Van den Wyngaert","year":"2009","journal-title":"Int J Clin Dent"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","article-title":"Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome.","volume":"20","author":"Van den Wyngaert","year":"2009","journal-title":"Ann Oncol"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","article-title":"Natural history of osteonecrosis of the jaw in patients with multiple myeloma.","volume":"26","author":"Badros","year":"2008","journal-title":"J Clin Oncol"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.joms.2006.07.012","article-title":"Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?","volume":"65","author":"Engroff","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcms.2008.12.004","article-title":"Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction.","volume":"37","author":"Mucke","year":"2009","journal-title":"J Craniomaxillofac Surg"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2307\/2531021","article-title":"Sample-size formula for the proportional-hazards regression model.","volume":"39","author":"Schoenfeld","year":"1983","journal-title":"Biometrics"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox's regression model for counting processes: a large sample study.","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Statist"},{"key":"R16-4-20210204","article-title":"Epidemiology: Study Design and Analysis.","author":"Woodward","year":"2005"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1902\/jop.1994.65.4.330","article-title":"Technetium 99m-MDP scintigraphy of patients undergoing implant prosthetic procedures: a follow-up study.","volume":"65","author":"Meidan","year":"1994","journal-title":"J Periodontol"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.","volume":"67","author":"O'Ryan","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1200\/jco.2007.25.18_suppl.9052","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: risk factors and diagnostic utility of bone scans.","volume":"25","author":"O'Connor","year":"2007","journal-title":"J Clin Oncol"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.107.048785","article-title":"Bone scintigraphy and SPECT\/CT of bisphosphonate-induced osteonecrosis of the jaw.","volume":"50","author":"Dore","year":"2009","journal-title":"J Nucl Med"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.","volume":"14","author":"Raje","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R22-4-20210204","first-page":"247","article-title":"Utility of 18F-FDG PET\/CT in the evaluation of bisphosphonate related osteonecrosis of the jaw [abstract].","volume":"36","author":"Mittra","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0b013e3181feeb72","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:55:48Z","timestamp":1785783348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-201101000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e3181feeb72","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}